Multitarget Effects of Quercetin in Leukemia
Open Access
- 1 December 2014
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 7 (12) , 1240-1250
Abstract
This study proposes to investigate quercetin antitumor efficacy in vitro and in vivo, using the P39 cell line as a model. The experimental design comprised leukemic cells or xenografts of P39 cells, treated in vitro or in vivo, respectively, with quercetin; apoptosis, cell-cycle and autophagy activation were then evaluated. Quercetin caused pronounced apoptosis in P39 leukemia cells, followed by Bcl-2, Bcl-xL, Mcl-1 downregulation, Bax upregulation, and mitochondrial translocation, triggering cytochrome c release and caspases activation. Quercetin also induced the expression of FasL protein. Furthermore, our results demonstrated an antioxidant activity of quercetin. Quercetin treatment resulted in an increased cell arrest in G1 phase of the cell cycle, with pronounced decrease in CDK2, CDK6, cyclin D, cyclin E, and cyclin A proteins, decreased Rb phosphorylation and increased p21 and p27 expression. Quercetin induced autophagosome formation in the P39 cell line. Autophagy inhibition induced by quercetin with chloroquine triggered apoptosis but did not alter quercetin modulation in the G1 phase. P39 cell treatment with a combination of quercetin and selective inhibitors of ERK1/2 and/or JNK (PD184352 or SP600125, respectively), significantly decreased cells in G1 phase, this treatment, however, did not change the apoptotic cell number. Furthermore, in vivo administration of quercetin significantly reduced tumor volume in P39 xenografts and confirmed in vitro results regarding apoptosis, autophagy, and cell-cycle arrest. The antitumor activity of quercetin both in vitro and in vivo revealed in this study, point to quercetin as an attractive antitumor agent for hematologic malignancies. Cancer Prev Res; 7(12); 1240–50. ©2014 AACR.Keywords
This publication has 45 references indexed in Scilit:
- Apoptosis of Bone Marrow Mesenchymal Stem Cells Caused by Homocysteine via Activating JNK SignalPLOS ONE, 2013
- Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular ApoptosisJournal of Biological Chemistry, 2011
- Nonlinear Reduction in Risk for Colorectal Cancer by Fruit and Vegetable Intake Based on Meta-analysis of Prospective StudiesGastroenterology, 2011
- Network organization of the human autophagy systemNature, 2010
- P39/Tsugane cells are a false cell line contaminated with HL-60 cells and are not suitable for mechanistic studies in myelodysplastic syndromesHaematologica, 2010
- An Overview of the Molecular Mechanism of Autophagy2009
- Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent ApoptosisCancer Research, 2009
- Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progressionJournal of Cellular Biochemistry, 2008
- Targeting Receptor Tyrosine Kinases for Chemoprevention by Green Tea Catechin, EGCGInternational Journal of Molecular Sciences, 2008
- The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by PhosphorylationJournal of Biological Chemistry, 2002